Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 13/20 | 0.87 |
| ▸ | MAPT | P10636 | 12/20 | 0.87 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.87 |
| ▸ | TDP1 | Q9NUW8 | 11/20 | 0.87 |
| ▸ | POLB | P06746 | 11/20 | 0.87 |
| ▸ | MEN1 | O00255 | 10/20 | 0.87 |
| ▸ | APEX1 | P27695 | 7/20 | 0.87 |
| ▸ | RECQL | P46063 | 6/20 | 0.87 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.87 |
| ▸ | CTDSP1 | Q9GZU7 | 6/20 | 0.87 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.82 |
| ▸ | EP300 | Q09472 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 3/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.57 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.57 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6397402 | 1.00 | KMT2A (0.87) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL6395653 | 0.93 | TDP1 (0.75) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL6395650 | 0.93 | TDP1 (0.75) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL6395805 | 0.82 | POLB (0.84) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL29493548 | 0.82 | KMT2A (0.67) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL6395803 | 0.82 | POLB (0.84) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL5145246 | 0.80 | TDP1 (0.58) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL5145239 | 0.80 | TDP1 (0.58) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL15502270 | 0.77 | KMT2A (0.61) | KMT2AMAPTKDM4ETDP1POLB | |
| SCHEMBL5144989 | 0.76 | MAPT (0.70) | KMT2AMAPTKDM4ETDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050282840-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2005-12-22 | — | — | US | disclosed |
| US-6908719-B1 | Photosensitive compound and photosensitive composition | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282840-A1 | Methods of modulating neurotrophin-mediated activity | NGF, BDNF, NTRK2 | KMT2A 4410/4885MAPT 2096/4885KDM4E 4569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.